3 minute read

References

Next Article
Conclusion

Conclusion

1. BBC. (2021, March 3). Covid: Police break up ‘fake vaccine network’ in China and South Africa. Retrieved from https://www.bbc.com/news/world-africa-56270243

2. Carlson, R. (2016). Estimating the biotech sector’s contribution to the US economy. Nature Biotechnology, 34(3), 247–255. https://doi.org/10.1038/nbt.3491

Advertisement

3. CBP year in Review: Agency adapts to secure and Facilitate essential trade and TRAVEL amid Pandemic. (2021, February 4). Retrieved from https://www.cbp.gov/newsroom/national-media-release/cbp-year-review-agencyadapts-secure-and-facilitate-essential-trade

4. Choe, J., Crane, M., Greene, J., Long, J., Mwanga, J., Sharfstein, J.M., . . . Strodel, R. (2020, November). The pandemic and the supply chain addressing gaps in pharmaceutical production and distribution. Retrieved from https:// www.jhsph.edu/research/affiliated-programs/johns-hopkins-drug-access-and-affordability-initiative/publications/ Pandemic_Supply_Chain.pdf

5. Crew, B., Jia, H., & Zastrow, M. (2020). Rising stars in life sciences 2020. Nature, d41586-020-01234–01237. https:// doi.org/10.1038/d41586-020-01234-7

6. Cumbers, J. (2020, February 3). China’s Plan To Beat The U.S. In The Trillion-Dollar Global Bioeconomy. Forbes. https://www.forbes.com/sites/johncumbers/2020/02/03/china-now-out-invests-america-in-the-globalbioeconomy-by-30/#65286a687440

7. Cyranoski, D. (2018). China’s crackdown on genetics breaches could deter data sharing. Nature, 563(7731), 301–302. https://doi.org/10.1038/d41586-018-07222-2

8. Cyranoski, D. (2019). China set to introduce gene-editing regulation following CRISPR-baby furore. Nature, d41586019-01580–01581. https://doi.org/10.1038/d41586-019-01580-1

9. DEA. (2018). 2018 National Drug Threat Assessment. Retrieved from https://www.dea.gov/sites/default/ files/2018-11/DIR-032-18%202018%20NDTA%20final%20low%20resolution.pdf

10. Delgado, A. (2013). DIYbio: Making things and making futures. Futures, 48: 65-73. https://www.sciencedirect.com/ science/article/pii/S0016328713000281

11. Dludla, N. (2021, March 4). Hundreds of fake COVID-19 vaccines seized in South Africa, Interpol says. Reuters.

Available at https://www.reuters.com/article/us-health-coronavirus-safrica-crime/hundreds-of-fake-covid-19vaccines-seized-in-south-africa-interpol-says-idUSKBN2AW27Q

12. FDA. (2021, March 5). Drug Shortages. Retrieved from www.fda.gov/drugs/drug-safety-and-availability/drugshortages

13. 13. FDA (2021b). March 2021 Global Update. (pp. 1-27). Retrieved from https://www.fda.gov/media/146765/ download

14. FDA. (2021c, June 4). Drug Supply Chain Security Act (DSCSA). Retrieved from https://www.fda.gov/drugs/drugsupply-chain-integrity/drug-supply-chain-security-act-dscsa#:~:text=The%20Drug%20Quality%20and%20 Security,Congress%20on%20November%2027%2C%202013.&text=This%20will%20enhance%20FDA's%20 ability,%2C%20contaminated%2C%20or%20otherwise%20harmful.

15. Gold, E.R., Herder, M., and Trommetter, M. (2007). The Role of Biotechnology Intellectual Property Rights in the Bioeconomy of 2030. OECD International Futures Project on “The Bioeconomy to 2030: Designing a Policy Agenda.” Retrieved from https://www.oecd.org/futures/long-termtechnologicalsocietalchallenges/40925999.pdf

16. Government Accountability Office. (2019). HIGH-RISK SERIES: Substantial Efforts Needed to Achieve Greater Progress on

High-Risk Areas (GAO-19-157SP; High-Risk). Government Accountability Office. https://www.gao.gov/products/GAO19-157sp#summary

17. Gronvall, G.K. (2018). Safety, security, and serving the public interest in synthetic biology. Journal of Industrial

Microbiology & Biotechnology, 45(7): 463-466.

18. Hahn, S.M. (2020, February 27). Coronavirus (COVID-19) Supply Chain Update. US Food and Drug Administration. Retrieved from https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-supply-chainupdate

19. Hamilton, C. (2008). Intellectual property rights, the bioeconomy and the challenge of biopiracy. Genomics, Society and Policy, 4(26): 1-19.

20. Homedes N, Ugalde A. Mexican Pharmacies and Antibiotic Consumption at the US-Mexico Border. Southern Med Review (2012) 5;2:9-19

21. Kolodziejczyk, B. (2017, October 9). Do-it-yourself biology shows safety risks of an open innovation movement.

Brookings Institution. Available at https://www.brookings.edu/blog/techtank/2017/10/09/do-it-yourself-biologyshows-safety-risks-of-an-open-innovation-movement/

22. KPMG. (2017). Overview of China’s Cybersecurity Law. KPMG. https://assets.kpmg/content/dam/kpmg/cn/pdf/ en/2017/02/overview-of-cybersecurity-law.pdf

23. Labiotech.eu. (2018). Can DIY Biology Ever Become a Big Player in Biotech? Available at https://www.labiotech.eu/ in-depth/diy-biology-biohacking-biotech/

24. Landrain, T., Meyer, M., Perez, A.M., and Sussan, R. (2013). Do-it-yourself biology: challenges and promises for an open science and technology movement. Systems and Synthetic Biology, 7(3): 115-126. https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC3740105/

25. Ledford, H. (2020). CRISPR treatment inserted directly into the body for first time. Nature, 579(7798), 185–185. https://doi.org/10.1038/d41586-020-00655-8

26. Miao, H. (2021, March 26). WHO warns against sales of counterfeit Covid vaccines on the dark web. CNBC. Retrieved from https://www.cnbc.com/2021/03/26/who-warns-against-sales-of-counterfeit-covid-vaccines-on-the-dark-web. html

27. Mirchandani, P. (2020). Health Care Supply Chains: Covid-19 Challenges and Pressing Actions. Annals of Internal

Medicine, 173(4), 300-301. doi:10.7326/m20-1326

28. Molloy, J. (2020). New Prepring: Crisis-Critical Intellectual Property: Findings from the COVID-19 Pandemic. Open

Bioeconomy Lab. Retrieved from https://openbioeconomy.org/news/new-preprint-crisis-critical-intellectualproperty-findings-from-the-covid-19-pandemic/

29. Monast, J. (2018). Editing Nature: Reconceptualizing Biotechnology Governance. Boston College Law Review, 59(7). https://lawdigitalcommons.bc.edu/cgi/viewcontent.cgi?article=3701&context=bclr

30. Murch, R. S., So, W. K., Buchholz, W. G., Raman, S., & Peccoud, J. (2018). Cyberbiosecurity: An Emerging New Discipline to Help Safeguard the Bioeconomy. Frontiers in Bioengineering and Biotechnology, 6(39). https://doi.org/10.3389/fbioe.2018.00039

31. Rodriguez, S. (2020, April 27). Sweeping Mexican factory shutdown strains U.S. production of critical supplies. Retrieved from https://www.politico.com/news/2020/04/27/mexico-american-production-coronavirus-212971

32. Schondelmeyer, S.W., Seifert, J., Margraf, D.J., Mueller, M., Williamson, I., Dickinson, C., . . . Osterholm, M.T. (2020, October 21). COVID-19: The CIDRAP Viewpoint, Part 6: Ensuring a Resilient US Prescription Drug Supply. Retrieved from https://www.cidrap.umn.edu/sites/default/files/public/downloads/cidrap-covid19-viewpoint-part6.pdf

33. Sganga, N. (2021, February 18). Homeland security seizes more than 11 million counterfeit N95 in NATIONWIDE SCAM. Retrieved from https://www.cbsnews.com/news/n95-masks-counterfeit-homeland-security/

34. Siripurapu, A. (2021, January 26). What is the Defense Production Act? Council on Foreign Relations. Retrieved from: https://www.cfr.org/in-brief/what-defense-production-act

35. Straus, J. (2017). Intellectual property rights and bioeconomy. Journal of Intellectual Property Law & Practice, 12(7): 576-590. https://academic.oup.com/jiplp/article/12/7/576/3823280

36. Tocchetti, S. and Aguiton, S.A. (2015). Is an FBI Agent a DIY Biologist Like Any Other? A Cultural Analysis of a Biosecurity Risk. Science, Technology, & Human Values, 40(5): 825-853.

37. World Bank. (2020a). Research and development expenditure (% of GDP). https://data.worldbank.org/indicator/ GB.XPD.RSDV.GD.ZS

38. World Bank. (2020b). GDP (Current US$). The World Bank. https://data.worldbank.org/indicator/NY.GDP.MKTP.CD

This article is from: